| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.49 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |